Immunology 101: Why Intramuscular COVID-19 Vaccination Must Fail

Anonymous, Sucharit Bhakdi, Michael Palmer

Many countries are currently experiencing a wave of COVID-19 “breakthrough cases” in spite of high vaccination rates. In this paper, we explain the fundamental reason why such cases had to be expected: the antibodies induced by intramuscular vaccination will only circulate in the bloodstream, but they will not reach the surface of the mucous membranes in the upper airways. We also briefly discuss possible mechanisms of vaccine-induced immunopathology.

Latest articles

Euzebiusz Jamrozik The global response to the recent coronavirus pandemic has revealed...
Abdulrahman Koshak et al. Effective treatment for patients with the novel Coronavirus...
James A. Thorp et al. Objectives: Assess rates of adverse events (AE)...
VaxJustice.org The rates of death and injury from Covid-19 never justi ed...
Vernon Coleman When the first practical polio vaccine was made in the...
Mike Campbell The study involved about 200 hungry mosquitos biting a human...

Your donation helps us
stand up for health freedom!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Thank you!

The form has been submitted successfully!